✦ LIBER ✦

The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status

✍ Scribed by Liu, Shan; Wang, Deqiang; Chen, Bo; Wang, Yan; Zhao, Weihong; Wu, Jianqing

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-agent versus combination chemothe

✍ Mörth, Charlott; Valachis, Antonis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 804 KB

Single-Agent Epidermal Growth Factor Rec

✍ Nagla Abdel Karim; Salma Musaad; Abdul Rahman Jazieh 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

The safety and efficacy of gefitinib ver

✍ Chang, Chia-Hsuin; Chen, Kuan-Yu; Young-Xu, Yinong; Kurth, Tobias; Orav, E. John 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Efficacy and safety of erlotinib versus

✍ Tudor Ciuleanu; Lilia Stelmakh; Saulius Cicenas; Skaidrius Miliauskas; Alexandru 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 381 KB

A randomized study of chemotherapy with

✍ P. Lissoni; F. Paolorossi; A. Ardizzoia; S. Barni; M. Chilelli; M. Mancuso; G. T 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB